Posts Tagged ‘China’

selected as Asias first liver cancer medical education center


AMC, acclaimed for both clinical and research achievements and experience in liver cancer treatment, was selected to serve as Asias first Continent Liver Cancer Medical Education Center. Physicians and staffers dealing with liver cancer treatment from the Departments of General Internal Medicine, Surgery and Radiology invited liver cancer specialists from across Asia and held PATH (Program for the Advancement of Therapy in Hepatocellular Carcinoma) to introduce AMCs advanced treatment systems and share ideas on better treatment options. The program was carried out in 8 sessions for 3 days, bringing together 20 liver disease experts from China, India and Thailand and training them on cutting-edge liver cancer treatment plans offered by AMC. For the duration of the program, international physicians took a tour around operating rooms and observed radiotherapy procedures carried out in the Angiography Room of the Department of Radiology. This designation of a PATH education center is the fourth worldwide and the first in Asia. It is expected to provide momentum for AMC to strengthen its presence and promote its superior medical technologies in the global market.

国际肿瘤中心介绍


We have located the best hospital in China for foreign advanced-cancer patients to be treated with a combination of gene therapy (Gendicine), immunotherapy (CIK or DC-CIK biotherapy), Cancer Stem Cell Targeted Treatment, a powerful anti-angiogenosis drug (Endostar), mild chemotherapy, HIFU non-invasive or Croysurgery minimal invasive surgery and traditional Chinese medicine (herb). This combined treatment is only available at the Beijing GreatWall International Cancer Center (BGWICC). It is very effective for pancreatic cancer, lung cancer, ovarian cancer,kidney cancer, prostate cancer, colorectal cancer, liver cancer, and breast cancer and it has very little or no side effects. BGWICC has successfully treated patients suffering from a number of advanced cancers with very encouraging results of more than 65% effective rate for liver, lung, pancreas, colorecta, ovary, breast cancer and relative metastasis. Patients include overseas patients from Turkey, Netherland, Australia, US, Canada, Germany, Britain and Singapore. Many patients had already failed to respond to varieties of chemotherapy regimens when they came and they achieve impressive efficacies here in BGWICC. For us …… Web: www.celltherapybeijing.com Patient Service Office Eel:(0086-10)51520752 Email: info@bgwicc.com

Liver Cancer Statistics


In this video, Hans Rosling uses liver cancer statistics to show how cancer data from IARC ( International Agency for research on Cancer) can be displayed as moving bubbles in Gapminder World. In this visual way, you can easily compare data for the most common cancers and rapidly understand that each of them have different distributions in the world. Liver cancer is mainly caused by chronic infection by the Hepatitis B virus (and also by the Hepatitis C virus). As this infection is most common in China and other parts of East Asia, as well as in Africa South of the Sahara, it is the countries in these regions that bear the main burden of Liver Cancer in the World (independent of if they have low, middle or high income). Comparing gender differences indicate that higher alcohol consumption in men may explain why the rate of liver cancer in men is twice as high as in women. is.gd – New cases of liver cancer per 100 000 men (with size showing the total number of new cases of liver cancer)